Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Smart Nanomaterials for Pharmaceutical and Biological Applications"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2612
Special Issue Editor
E-Mail Website1 Website2 Website3
Interests: HPTLC; HPLC, nanotechnology; GC-MS; pharmaceutical analysis; phytochemical analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Smart nanomaterials have tremendous applications in pharmaceutical and biomedical fields. Innovative active biomolecule drug delivery systems have advanced significantly since the discovery of smart nanomaterials-based drug delivery systems, such as PLGA nanoparticles, chitosan nanoparticles, metallic nanoparticles, and self-nanoemulsifying drug delivery systems (SNEDDSs). In recent years, there has been a great deal of interest in the use of smart nanomaterials as drug delivery vehicles for therapeutic targeting of certain cells. These nanosized materials have the following benefits: biocompatibility, biodegradability, reduced toxicity, drug delivery efficiency, drug targeting efficiency, increased solubility, bioavailability, and bioactivity. These nanomaterials can also include a wide variety of therapeutically active biomolecules. These nanomaterials-based drug delivery systems can also increase the active therapeutic biomolecules’ pharmacokinetic and pharmacodynamic effectiveness, enabling a more prolonged, focused, and regulated drug delivery system. Recent studies have demonstrated advancements in drug delivery systems based on nanomedicine for potential therapeutic targeting.
This Special Issue intends to compile recent advancements and future possibilities in the design, development, characterization, and biological assessment of drug delivery systems for active therapeutic biomolecules based on smart nanomaterials.
Dr. Faiyaz Shakeel
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chitosan nanoparticles
- PLGA nanoparticles
- metallic nanoparticles
- solid lipid nanoparticles
- self-nanoemulsifying drug delivery systems